1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-101842 ND-646

Others

Cancer

Oct-2017 ND-646
HY-100747 PSB-12379

Adenosine Receptor

Cancer

Oct-2017 PSB-12379
HY-B2226 Sodium copper chlorophyllin

HIV; Influenza Virus

Infection

Oct-2017 Sodium copper chlorophyllin
HY-105008 Secoisolariciresinol diglucoside

Others

Cardiovascular Disease

Oct-2017 Secoisolariciresinol diglucoside
HY-B2184 Sofalcone

Autophagy

Infection;

Inflammation/Immunology

Oct-2017 Sofalcone
HY-107439 E3 Ligase Ligand-Linker Conjugates 20

Epigenetic Reader Domain; E3 Ligase Ligand-Linker Conjugate

Cancer

Oct-2017 E3 Ligase Ligand-Linker Conjugates 20
HY-107438 E3 Ligase Ligand-Linker Conjugates 19

Epigenetic Reader Domain; E3 Ligase Ligand-Linker Conjugate

Cancer

Oct-2017 E3 Ligase Ligand-Linker Conjugates 19
HY-107440 E3 Ligase Ligand-Linker Conjugates 21

Epigenetic Reader Domain; E3 Ligase Ligand-Linker Conjugate

Cancer

Oct-2017 E3 Ligase Ligand-Linker Conjugates 21
HY-14937 Succinobucol

Others

Cardiovascular Disease;

Inflammation/Immunology

Oct-2017 Succinobucol
HY-103640 WR-1065 dihydrochloride

MDM-2/p53

Cancer

Oct-2017 WR-1065 dihydrochloride
HY-B1383 Dichlorisone acetate

Others

Inflammation/Immunology

Oct-2017 Dichlorisone acetate
HY-103350 CA-074

Cathepsin

Cancer;

Neurological Disease

Oct-2017 CA-074
HY-N1505 Loureirin A

Akt

Cardiovascular Disease

Oct-2017 Loureirin A
HY-N1504 Loureirin B

PAI-1; Potassium Channel; ERK; JNK

Metabolic Disease

Oct-2017 Loureirin B
HY-D0205 (RS)-Carbocisteine

Others

Others

Oct-2017 (RS)-Carbocisteine
HY-18563 4-Phenoxybenzylamine

HCV

Infection

Oct-2017 4-Phenoxybenzylamine
HY-N0470 L-Lysine hydrochloride

Others

Cardiovascular Disease;

Endocrinology;

Infection;

Inflammation/Immunology

Oct-2017 L-Lysine hydrochloride
HY-101479 Iclaprim

Bacterial

Infection

Oct-2017 Iclaprim
HY-102081 2OH-BNPP1

Others

Cancer

Oct-2017 2OH-BNPP1
HY-107379 AKR1C3-IN-1

Others

Others

Oct-2017 AKR1C3-IN-1